Recombinant Human sTRAIL Receptor-1

Grouped product items
SizePrice Qty
10µg
$80.00
50µg
$195.00
100µg
$300.00
500µg
$900.00
1mg
$1,500.00
Catalog Number : 310-18

description

TRAIL Receptor-1/DR4 and TRAIL Receptor-2/DR5 belong to the TNFR superfamily of transmembrane proteins and contain a cytoplasmic "death domain, " which can activate the cell's apoptotic machinery. These receptors are activated by binding to either membrane anchored or soluble TRAIL/Apo2L. Recombinant human soluble TRAIL Receptor-1/DR4 is a 22.7 kDa protein (215 amino acid residues) consisting of the TNFR homologous, cysteine rich portion of the extracellular domain.

Additional Information

Source:
E. Coli
Purity:
Above 98% as determined by SDS-PAGE Analysis.
Cross Reactivity:
NULL
Biological Activity
Measured by its ability to inhibit apoptosis in LN-18 cells.  The expected ED50 for this effect is 0.4 -0.5 µg/ml.
AA Sequence
MSGTGAAAA TPSKVWGSS AGRIEPRGG GRGALPTSM GQHGPSARA RAGRAPGPR PAREASPRL RVHKTFKFV VVGVLLQVV PSSAATIKL HDQSIGTQQ WEHSPLGEL CPPGSHRSE RPGACNRCT EGVGYTNAS QQLFACLPC TACKSDEEE RSPCTTTRN TACQCKPGT FRNDNSAEM CRKCSTGCP RGMVKVKDC TPWSDIECV HKESGNGHN
Research Interest:Receptors
Application:FA
Protein Cross Reactivity:NULL
© BioGems International, Inc. All rights reserved.